Key Details
Price
$0.34Annual EPS
-$0.00Annual ROE
-50.76%Beta
1.24Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
N/ARecent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with KLTO included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Klotho Neurosciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
KLTO
prismmediawire.com23 October 2024
Discoverer of Klotho gene further strengths KLTO Scientific Advisory Board New York, NY, October 23, 2024 – PRISM MediaWire – Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr.
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
KLTO
globenewswire.com23 October 2024
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and gene therapies for aging and age-related diseases, is proud to announce the appointment of Dr. Makoto Kuro-o to its Scientific Advisory Board. Dr. Kuro-o, a distinguished Japanese physician-scientist, is widely recognized as the pioneer behind the discovery of the Klotho gene, often referred to as the "anti-aging gene.
FAQ
- What is the primary business of Klotho Neurosciences?
- What is the ticker symbol for Klotho Neurosciences?
- Does Klotho Neurosciences pay dividends?
- What sector is Klotho Neurosciences in?
- What industry is Klotho Neurosciences in?
- What country is Klotho Neurosciences based in?
- Is Klotho Neurosciences in the S&P 500?
- Is Klotho Neurosciences in the NASDAQ 100?
- Is Klotho Neurosciences in the Dow Jones?
- When does Klotho Neurosciences report earnings?
What is the primary business of Klotho Neurosciences?
Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
What is the ticker symbol for Klotho Neurosciences?
The ticker symbol for Klotho Neurosciences is NASDAQ:KLTO
Does Klotho Neurosciences pay dividends?
No, Klotho Neurosciences does not pay dividends
What sector is Klotho Neurosciences in?
Klotho Neurosciences is in the Healthcare sector
What industry is Klotho Neurosciences in?
Klotho Neurosciences is in the Biotechnology industry
What country is Klotho Neurosciences based in?
Klotho Neurosciences is headquartered in United States
Is Klotho Neurosciences in the S&P 500?
No, Klotho Neurosciences is not included in the S&P 500 index
Is Klotho Neurosciences in the NASDAQ 100?
No, Klotho Neurosciences is not included in the NASDAQ 100 index
Is Klotho Neurosciences in the Dow Jones?
No, Klotho Neurosciences is not included in the Dow Jones index
When does Klotho Neurosciences report earnings?
The date for Klotho Neurosciences's next earnings report has not been announced yet